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OBSERVATIONS ON INDOL-POSITIVE PROTEUS
Gram-negative rods have assumed a major role in infectious disease, par-
ticularly among hospitalized patients. Among the Enterobacteriaceae, mem-
bers of the genus Proteus may cause infections of the urinary' and respira-
tory2 tracts, as well as meningitis,8 soft tissue infections,' and septicemia.'
However, mere isolation of these bacteria did not necessarily indicate the
presence of infection. The most frequently encountered species has been
the indol-negative P. mirabilis which has been studied from an epidemio-
logical viewpoint, too.'-'
The three indol-positive Proteus (IPP) species, P. morganii (PMo),
P. vulgaris (PV), and P. rettgeri (PR), are encountered far less often in
clinical specimens. In 1967, we isolated a significant number of them, and
the present study examines some factors of distribution, antimicrobial sen-
sitivity, clinical significance, and transmission of these organisms.
MATERIALS AND METHODS
Selection of cultures
This retrospective study covers a nine-month period from January 1 until Septem-
ber 30, 1967. Only those patients in whom infection (but not necessarily at the site
of later isolation) according to usual clinical criteria was suspected, had been cul-
tured. Records of the Bacteriology Laboratory at the Yale-New Haven Hospital were
reviewed for IPP isolations. Excluded from evaluation were (a) cultures from pedi-
atric patients up to ten years of age, as these are processed in a different laboratory
at this hospital, (b) cultures in which IPP were found in small numbers on the pri-
mary plates (less than 1+ growth as defined below, or less than 100,000 bacteria per
ml. of urine) or in the enrichment broth only, (c) cultures from stools, as IPP may
have been part of the normal flora.
Isolation and identification of IPP
Inoculation techniques were described in an earlier paper.'0 On urine plates inocu-
lated with 0.001 ml., colony counts were performed; on plates from other specimens,
a quantitative estimate of growth ranging from 1+ (little) to 4+ (abundant) was
made. Non-lactose-fermenting colonies were picked from Desoxycholate Agart plates
and subjected to identification procedures described elsewhere.' IPP species were
diagnosed according to test results published by the National Communicable Disease
Center."2 In the absence of phage typing or serotyping, different strains were arbi-
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trarily defined on the basis of different antimicrobial sensitivities and/or isolation from
various wards at different times.
Antimicrobial sensitivity testing
This was done with a standardized single high potency disc method'8 using Sensi-
Discs* of nine antimicrobials: kanamycin (30 pgm), nalidixic acid (30 pgm), chlor-
amphenicol (30 ,ugm), streptomycin (10 agm), tetracycline (30 sgm), ampicillin (10
ugm), cephalothin (30 jugm), colistimethate sodium (10 jpgm), and nitrofurantoin
(100 Ogm).
Statistical evaluation
The t-test (Student) and the Fourfold Contingency TestU were used at the 1%
level.
RESULTS
Freqency and distribution of IPP
Table 1 lists numerical data on patients, strains, and isolations. During
the study period, the hospital counted six times as many outpatients as in-
patients. However, IPP was isolated seven times more often from inpatients
than from outpatients. On a percentage basis of hospital beds, inpatients
with IPP isolations were distributed equally between medical and surgical
services.
Of all IPP strains isolated, PMo were found 2.6 times as often as PR
and 2.35 times as often as PV. There was an average of 15 strains per
month, with a minimum of six in April and a maximum of 33 in July. The
total patient count remained constant during the study period. P. nirabilis
TABLE 1. FREQUENCY OF IPP
PMo PV PR Total
rin 63 28 24 115
Patients out 5 4 3 12
Itotal 68 32 27 127
Different strains 81 34 31 146
Isolations (one per site) 88 42 32 162
Abbreviations:
C, contributory PC, probably contributory
CA, community acquired PMo, Proteus morganni
F, female PR, Proteus rettgeri
HA, hospital acquired PV, Proteus vulgaris
M, male RT, respiratory tract
NC, not contributory UT, urinary tract
0th, other Wd, wounds, pus, ear, eye
Pat, patients
* BioQuest, Cockeysville, Md.
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strains were isolated six times more frequently than all IPP strains to-
gether. Routine environmental cultures from operating, delivery, and
emergency rooms were consistently negative for IPP. Wards were not
checked.
Of all specimens received during the study period, 0.68% yielded IPP.
Follov-up and repeat cultures had been left to hospital staff and were in-
complete. Multiple isolations of the same strain from the same site were
made in approximately 10% of the individuals affected, and the same
strain was cultured from two or three different sites of the same individual
in about 4%. There was no evidence of cross infections or of clustering of
one strain on one ward.
AMixed vs. pure cultures
Table 2 demonstrates that over 80%o of all strains were found together
with other potential pathogens (over 50%'o with more than one). The spe-
cies most frequently isolated with PMo and PV were E. coli, Enterococci,
Pseufdomitonas aeruginosa, and Klebsiella. PR was isolated most commonly
witlh Pseudornonas aeruginosa and Enterococci. Sixty-six per cent of all
pure cultures came from urines.
Anitimicrobial sensitivities
Table 3 lists the numbers of sensitive and intermediate (moderately
sensitive) strains. Against all three species, kanamycin and nalidixic acid
were the most effective drugs. At least half of the PMo and PV strains
were sensitive to chloramphenicol, streptomycin, and tetracycline (with no
inter-species difference), whereas less than 27%o of the PR strains were
sensitive to these drugs. The response of all species to ampicillin, cephalo-
TABLE 2. OCCURRENCE OF IPP WITH OTHER POTENTIAL
PATHOGENS (Number of strains)
PMo PV PR
Total strains 81 34 31
Pure or mixed with local normal flora 7 4 6
Mixed with potential pathogens 74 30 25
E. coli 40 10 6
Enterococci 33 7 11
Pseudomonas aeruginosa 27 5 10
Klebsiella 26 5 6
Proteus mirabilis 18 2 7
Staphylococci (coag. pos.) 13 5 4
Enterobacter 8 5 2
Others 27 8 17
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TABLE 3. ANTIMICROBIAL SENSITIVITIES
(Number of sensitive and intermediate8 strains)
Antimicrobial druig PMo PV PR
Total strains 81 34 31
Kanamycin 76 33 31
Nalidixic Acid 76 31 24
Chloramphenicol 61 31 6
Streptomycin 53 25 8
Tetracycline 48 18 3
Ampicillin 8 4 5
Cephalothin 2 5 3
Colistimethate sodium* 2 2 4
Nitrofurantoin 54 8 0
* Colistin.
thin, and colistimethate sodium was equally poor. Nitrofurantoin affected
about two thirds of the PMo and one quarter of the PV strains, but was
ineffective against PR.
There was no difference in the sensitivities between strains isolated from
different categories of patients (e.g., those on previous antimicrobial treat-
ment vs. those on no such treatment; with hospital-acquired infections vs.
community-acquired ones; with pure cultures vs. mixed ones). One-way
cross-resistance was present in all species between kanamycin and nalidixic
acid. Sensitivity "patterns" diagnostic for a particular species were not
observed.
Site of isolation, sex, and age of patients
Table 4 relates these factors. During the study period, 66%o of all in-
TABLE 4. RELATIONSHIP BETWEEN SITE OF ISOLATION OF IPP, AGE,
AND SEX OF PATIENTS (Number of strains)
Age UT RT Wd Blood 0th Total Percent of
Species (years) M F AM F M F M F M F M F total
PMo 11-50 3 2 1 0 6 7 0 0 1 1 11 10 25.9
51-90 9 6 17 4 15 2 0 1 2 4 43 17 74.1
Total 12 8 18 4 21 9 0 1 3 5 54 27 100.0
PV 11-50 0 3 0 0 3 4 0 0 00 3 7 29.4
51-90 5 2 8 0 4 3 0 0 1 1 18 6 70.6
Total 5 5 8 0 7 7 0 0 1 1 21 13 100.0
PR 11-50 3 0 0 0 2 1 0 0 0 0 5 1 19.3
51-90 11 4 1 1 5 0 1 0 1 1 20 5 80.7
Total 14 4 1 1 7 1 1 0 1 1 25 6 100.0
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patients (with and without IPP) had been under 50 years of age, and the
male :female ratio had been 1:1. The majority of patients with IPP, how-
ever, were over 50 and male. Strains isolated from different sites showed
some pertinent features.
Urinary tract strains made up between 25%c and 30%o of the PMo and
PV, but 58% of the PR strains. As would be expected in a population with
urinary tract infections, the older age group was affected 3-4 times more
frequently than the younger one. A clear predilection for males was seen
in PR only.
Respiratory tract strains also comprised about 25%o of the PMo and PV
but only 6%o of the PR strains. They were isolated from the sputa and in
five instances from tracheal aspirates. They came almost exclusively from
patients in the older age group. Here, PMo and PV showed a predilection
for males.
Strains from wounds, pus, etc. They comprised approximately 40%0 of
the PMo and PV strains and 25%o of the PR strains. No age group pre-
dominated. Males were more often affected by PMo and PR than were
females.
Strains from blood. They were isolated from two patients in their
seventies.
Clinical conditions
Table 5 lists chronic clinical conditions of patients with IPP prior to the
isolation of the organisms. It is apparent that most patients did have pre-
existing disease; only eight with PMo, two with PV, and one with PR
seemed free of it. IPP was isolated particularly frequently following urinary
tract instrumentation and following operations (PMo from wounds).
The acute illnesses presented clinically as urinary tract infection, pneu-
monitis (none primarily due to IPP), wound infection, and Gram-negative
septicemia.
Pathogenic significance
Table 6 shows the relationship of IPP to infection at a specific site.
Strains were called "contributory" if they were found in pure culture or if
they predominated in mixed cultures from sites where infection was clini-
cally present. They were called "probably contributory" if they occurred
together in the same quantity with other pathogens at the site of clinical
infection. If there was no evidence of an infection at the site of isolation,
they were called "non-contributory." Overall, contributory, and probably
contributory strains exceeded non-contributory ones by a factor of two or
more in all species regardless of their origin from inpatients or outpatients.
As expected, non-contributory strains were not found among the urinary
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TABLE 5. PREEXISTING CLINICAL CONDITIONS (Number of patients)
Isolation from
UT RT Wd
PMo PV PR PMo PV PR PMo PV PR
Total patients 20 10 18 22 8 2 26 14 7
Primary urinary tract
disorder 9 4 12 3 1 0 8 1 1
Indwelling catheter or
other previous urinary
tract instrumentation 9 4 16 2 0 0 4 0 4
Chronic pulmonary disease 4 2 5 0 3 0 0 0 1
Previous respiratory
tract instrumentation 1 1 1 6 4 1 1 0 0
Cardiovascular disease 4 2 7 8 6 0 6 4 1
Malignancy 5 2 5 4 2 0 7 3 4
Other major illness
(non-infectious) 1 3 6 4 1 1 8 7 2
Postoperative state 5 3 8 10 2 0 18 6 1
Diabetes mellitus 1 2 3 4 1 0 3 3 0
tract isolates. On the other hand, they were encountered relatively fre-
quently in sputa and wounds invaded with PMo. Almost all PR strains
were contributory.
Commnt-unity-acquired and hospital-acquired strains
Table 7 compares data on these strains. "Hospital-acquired" ones are
defined as those that either could not be isolated from the patient at the
TABLE 6. RELATIONSHIP BETWEEN IPP ISOLATION AND DISEASE
(Number of strains)
Species Designation1 UT RT Wd 0th Total
PMo C 19 10 21 3 53
PC 1 3 2 0 6
NC 0 9 7 6 22
PV C 7 6 8 0 21
PC 3 1 4 0 8
NC 0 1 2 2 5
PR C 17 1 6 3 27
PC 1 0 1 0 2
NC 0 1 1 0 2
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time of admission or were found only when clinical evidence of infection
had become apparent after admission. "Community-acquired" strains were
those isolated from patients who were clinically ill at the time of their first
admission, or were in the process of becoming ill.
Overall, hospital-acquired strains were found two (PMo, PV) to six
(PR) times more frequently than community-acquired ones; they pre-
vailed by an even wider margin in urine specimens. Fifty per cent of them
were isolated after local instrumentation (Foley catheterization, cystoscopy;
bronchoscopy, intermittent positive pressure breathing) or operation. The
percentage of contributory strains was slightly higher in the hospital-
acquired group. The greater affinity for males and patients over 50 years,
ol)served in both kinds of strains, reflects our patient statistics (Table 4).
Surprisingly, patients on previous antimicrobial treatment (which had
been largely effective against IPP strains) harbored IPP less frequlently
than those without previous treatment. This was a consistent finding ir-
respective of the origin of the strain from community or hospital. Thus,
antimicrobial treatment was not a significant factor in the acquisition of
a strain in the hospital.
Frequtency of hospitalization
As Table 8 demonstrates, PR was the only species that was more often
isolated on a patient's second or subsequent hospital stay than on his first
one (other differences are not significant). Data on the relationship be-
tween hospitalization days and isolation of IPP could not be obtained witl
accturacy since not all cultures were taken at identical times durinog the
patients' illnesses.
Death anid IPP isolation
Of the 22 patients that died, 14 had harbored PMo, five, PV, and tlhree,
PR. Only one (with PV) had been under 50 years of age. All patients
with PMo and PV and two with PR isolations who died succumbed to
causes not attributable to IPP infection. One patient died from a PR septi-
cemnia secondary to p)yelonephritis caused by the same organism.
TABLE 8. HOSPITALIZATIONS AND IPP ISOLATIONS
(Number of patients)
Hospital admissiont for
underl!ying disease PMo PV PR
First 28 11 6
Second or more 35 17 18
Outpatients 5 4 3
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DISCUSSION
The retrospective character of this study accounts for several limitations
which should be taken into consideration.
1. As in many studies of a similar nature, comparative data for the fre-
quency of IPP and the incidence of preexisting conditions in the entire
hospital population as well as in a non-hospitalized population of equal
size are lacking.
2. The incidence of preexisting conditions, specifically of chronic urinary
and respiratory tract disease, would be higher in any group consisting of
patients over 50 years of age.
3. Estimates of hospital-acquisition of strains and of their contribution
to disease are beclouded by subjective factors.l"
4. Many patients were either not cultured at the time of their admission,
or there was no record of earlier cultures from other hospitals. These fac-
tors have influenced the number of community-acquired strains. It was for
this reason that an assessment of the rate of superinfections with IPP was
not undertaken.
5. In about 96% of the patients with IPP isolation, only one site was
cultured. This fact, as well as the factors mentioned in (1.) have probably
influenced the number of non-contributory strains recorded. In particular,
stool cultures were either not taken or not evaluated for IPP. This made
it impossible to decide whether a strain was of exogenous or endogenous
origin, since IPP species are known to occur in normal stools.'7 The ab-
sence of ward epidemics and the occurrence of community-acquired strains
suggest an endogenous origin for at least a substantial proportion of our
isolates.4 However, other authors have observed exogenous IPP and P.
mtirabilis infections.8'9'8199 The organisms have been cultured from ther-
mometers, bedpans, the air close to infected patients, and the hands of the
hospital staff.918
In spite of these limitations, a number of pertinent facts can be deduced
from our study.
PMo isolations occurred about 2Y2 times more frequently than PV and
PR. It is well known that aside from the above mentioned factors, the fre-
quency of isolation depends on the patient material of the hospital (age,
chronicity of disease, length of hospitalization, incidence of cross infections).
Our species ratio is, therefore, not directly comparable to that recorded
by other authors.``""" The greater prevalence of P. mirabilis over the IPP,
however, has been observed repeatedly.1"''l'f
Antimicrobial sensitivity data for IPP also vary considerably, depending
on the techniques used (MIC determinations, various diffusion tests with
different interpretations). Our results with kanamycin, nalidixic acid,
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chloramphenicol, ampicillin, cephalothin, and colistimethate sodium are
consistent, within the limitations of the disc method,' with previously re-
ported 1IIC values.`~As compared with strains from other laboratories,
more of our PMo and PV strains were sensitive to tetracycline; also, more
of our PNr strains were sensitive to nitrofurantoin, while less were sensitive
to streptomycin.21"'9 It is to be noted, however, that the term "strain" is
rarely defined. Carbenicillin, which seems effective against a high per-
centage of IPP,' had not been available to us at the time of the study.
P. miirabilis strains are, on the whole, more sensitive than IPP to anti-
microbials: resistance to tetracycline, polymyxin B, colistimethate sodium,
and nitrofurantoin is most frequently observed,'"N'" whereas the other
drugs listed in Table 3, as well as penicillin in high dosages, are effective
against a high percentage of strains.
The lack of difference in sensitivity between hospital- and community-
acquired strains has been observed in P. mirabilis causing urinary tract in-
fection.' The degree of susceptibility, moreover, has been found independent
of the site from which Proteus was cultured.' In these respects, the genus
Proteuis differs from the genera Klebsiella and Enterobacter.'
Certain host factors associated with other Gram-negative infections are
apparently associated with IPP, too. In contrast to P. mirabilis strains,'
IPP strains were more often hospital-acquired than community-acquired.
About 80% of patients with IPP showed preexisting conditions (which
certainly surpassed the frequency found in the entire hospital population).
A similar figure was observed in the urinary tract infections with P.
rnirabilis.' A higher percentage was only seen in Serratia infections." How-
ever. Diabetes mellitus, associated in one series in about 25% with urinary
tract infection due to Proteus,l was not present in a significant number of
the IPP patients. Also, only 22% (PMo) to 33% (PR) of the IPP pa-
tients had received previous antimicrobial treatment. This percentage is
much lower than recorded in many other strains of Gram-negative rod
infections,'1'1 and somewhat lower than that recorded for urinary tract
infections with P. mirabilis. The importance of instrumentation, well docu-
mented for infections of the urine with P. nzirabilis,' Klebsiella,'6 and Ser-
ratia," is significant in our study as well.
As far as the interpretation of a strain as "contributory" is concerned, a
particular problem arose with mixed cultures. We observed no case of
pneumonia due to IPP alone (as described by others2). Cultures from the
respiratory tract were mostly mixed with Klebsiella, E. coli, and Pneu-
ntococci, and these turned out to be of "primary clinical importance"'9 even
though IPP may have predominated in the culture. Non-contributory
strains most often replaced local normal flora.
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There were inter-species differences between PMo and PV on one side
and PR on the other. The latter and least frequent species isolated was most
resistant to antimicrobials (while PMo and PV differed only in their sus-
ceptibility to nitrofurantoin), had a significantly higher preference for
male patients, and also preferred those previously hospitalized. Urines
were its most frequent source (a fact which would account for the higher
percentage of contributory strains), and more strains were hospital-
acquired than in the other species.
The virulence of IPP strains for animals is variable.'7 In our patients,
highly virulent strains were probably rare: we saw only two cases of over-
whelming infection, 20%o of all strains were non-contributory, and among
the 22 (19%) of our patients that died, only one succumbed to a cause
(PR septicemia) that was immediately attributable to IPP.
SUMMARY
A retrospective study of 146 strains of indol-positive Proteuts species
isolated from adults is presented. The organisms, frequently resistant to
many antimicrobial drugs, were most often isolated from mixed cultures,
with a ratio of 2.6 (P. morganii): 1.1 (P. vulgaris): 1.0 (P. rettgeri).
About 80%o of the patients showed preexisting disease. Between 70% and
80%o of the strains were found in patients over 50 years of age, were prob-
ably or certainly contributory to clinical illness, and were acquired in the
hospital. The latter strains were particularly conspicuous in patients with
previous instrumentation, but showed no association to previous anti-
microbial treatment. In several respects, P. rettgeri differed from P.
mnorganii and P. vulgaris.
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